CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Heart Failure and Atrial Fibrillation, Like Fire and Fury
|<<... 7 8 9 10 11 12 13 ...>>|

Clinical Trial2018 Apr 12;378(15):1386-1395.

JOURNAL：N Engl J Med. Article Link

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

Mehra MR, Goldstein DJ, MOMENTUM 3 Investigators. Keywords: Magnetically Levitated Left Ventricular Assist Device; heart failure; pump thrombosis;

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top